Related Experiment Video
Updated: May 23, 2026
09:08
Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice
Published on: July 11, 2016
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M Levin1, Darren L Bates, Aaron M Ring
1Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California 94305, USA.
Nature
|March 27, 2012
Summary
Researchers engineered an interleukin-2 (IL-2) superkine that enhances T cell responses and anti-tumor activity without needing CD25. This superkine mimics CD25
Area of Science:
- Immunology and Molecular Biology
- Protein Engineering and Drug Discovery
Background:
- Interleukin-2 (IL-2) is a crucial cytokine for immune cell growth, with therapeutic potential in cancer and AIDS.
- IL-2's clinical use is limited by adverse effects and its reliance on CD25 (IL-2Rα) for high-affinity binding to T cells.
- Naive T cells require CD25 expression to become sensitive to IL-2, presenting a barrier for effective immunotherapy.
Purpose of the Study:
- To engineer an IL-2 variant (superkine) that bypasses the need for CD25 expression.
- To enhance IL-2's binding affinity for IL-2Rβ, thereby increasing its potency and specificity.
- To improve therapeutic efficacy and reduce side effects associated with IL-2 immunotherapy.
Main Methods:
- In vitro evolution was employed to engineer an IL-2 superkine with enhanced binding to IL-2Rβ.
- Crystal structures and molecular dynamics simulations were used to analyze the superkine's conformation and binding interactions.
- Functional assays assessed STAT5 phosphorylation, T cell proliferation, and immune responses in vitro and in vivo.
Main Results:
- The engineered IL-2 superkine demonstrated increased binding affinity for IL-2Rβ, stabilizing a high-affinity receptor-binding conformation.
- The superkine induced potent STAT5 phosphorylation and T cell proliferation independently of CD25 expression.
- In vivo studies showed superior expansion of cytotoxic T cells, improved anti-tumor responses, and reduced expansion of regulatory T cells and pulmonary edema compared to wild-type IL-2.
Conclusions:
- In vitro evolution successfully mimicked the functional role of CD25, creating an IL-2 superkine with enhanced potency and specificity.
- This CD25-independent IL-2 superkine offers a promising strategy for improving IL-2-based immunotherapies.
- The findings have significant implications for developing more effective and safer treatments for immune disorders and cancer.
Related Concept Videos
02:53Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...